These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21625751)

  • 1. Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment.
    Miguita K; Cordeiro Q; Shavitt RG; Miguel EC; Vallada H
    Arq Neuropsiquiatr; 2011; 69(2B):283-7. PubMed ID: 21625751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of SLC6A4 and HTR2A genes with obsessive-compulsive disorder: Influence of the STin2 polymorphism.
    Gomes CKF; Vieira-Fonseca T; Melo-Felippe FB; de Salles Andrade JB; Fontenelle LF; Kohlrausch FB
    Compr Psychiatry; 2018 Apr; 82():1-6. PubMed ID: 29331882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.
    Corregiari FM; Bernik M; Cordeiro Q; Vallada H
    Clinics (Sao Paulo); 2012; 67(4):335-40. PubMed ID: 22522758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder.
    Meira-Lima I; Shavitt RG; Miguita K; Ikenaga E; Miguel EC; Vallada H
    Genes Brain Behav; 2004 Apr; 3(2):75-9. PubMed ID: 15005715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder.
    Cengiz M; Okutan SN; Bayoglu B; Sakalli Kani A; Bayar R; Kocabasoglu N
    Genet Test Mol Biomarkers; 2015 May; 19(5):228-34. PubMed ID: 25751280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study between obsessive-compulsive disorder and serotonergic candidate genes.
    Saiz PA; Garcia-Portilla MP; Arango C; Morales B; Bascaran MT; Martinez-Barrondo S; Florez G; Sotomayor E; Paredes B; Alvarez C; San Narciso G; Carreño E; Bombin I; Alvarez V; Coto E; Fernandez JM; Bousoño M; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):765-70. PubMed ID: 18191318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.
    Di Bella D; Erzegovesi S; Cavallini MC; Bellodi L
    Pharmacogenomics J; 2002; 2(3):176-81. PubMed ID: 12082589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.
    Baca-Garcia E; Vaquero-Lorenzo C; Diaz-Hernandez M; Rodriguez-Salgado B; Dolengevich-Segal H; Arrojo-Romero M; Botillo-Martin C; Ceverino A; Piqueras JF; Perez-Rodriguez MM; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):416-20. PubMed ID: 17174018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.
    Zilles D; Meyer J; Schneider-Axmann T; Ekawardhani S; Gruber E; Falkai P; Gruber O
    Eur Arch Psychiatry Clin Neurosci; 2012 Dec; 262(8):667-76. PubMed ID: 22454241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism.
    Hasler G; Kazuba D; Murphy DL
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):403-8. PubMed ID: 16583440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of early onset obsessive-compulsive disorder: Symptom dimensions and association analysis with polymorphisms of the serotonin transporter gene.
    Kenezloi E; Lakatos K; Horvath EZ; Sasvari-Szekely M; Nemoda Z
    Psychiatry Res; 2018 Oct; 268():388-391. PubMed ID: 30121542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways.
    Frisch A; Michaelovsky E; Rockah R; Amir I; Hermesh H; Laor N; Fuchs C; Zohar J; Lerer B; Buniak SF; Landa S; Poyurovsky M; Shapira B; Weizman R
    Eur Neuropsychopharmacol; 2000 May; 10(3):205-9. PubMed ID: 10793323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder.
    Tot S; Erdal ME; Yazici K; Yazici AE; Metin O
    Eur Psychiatry; 2003 Aug; 18(5):249-54. PubMed ID: 12927326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis between a VNTR intron 8 polymorphism of the dopamine transporter gene (SLC6A3) and obsessive- compulsive disorder in a Brazilian sample.
    Miguita K; Cordeiro Q; Siqueira-Roberto J; Shavitt RG; Castillo JC; Castillo AR; Miguel EC; Vallada H
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):936-41. PubMed ID: 18094849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serotonin transporter gene polymorphisms with obsessive-compulsive disorder (OCD) in a south Indian population.
    Tibrewal P; Kumar HB; Shubha GN; Subhashree D; Purushottam M; Thennarasu K; Reddy YC; Jain S
    Indian J Med Res; 2010 Dec; 132(6):690-5. PubMed ID: 21245616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.
    Dickel DE; Veenstra-VanderWeele J; Bivens NC; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
    Biol Psychiatry; 2007 Feb; 61(3):322-9. PubMed ID: 17241828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder.
    Grünblatt E; Marinova Z; Roth A; Gardini E; Ball J; Geissler J; Wojdacz TK; Romanos M; Walitza S
    J Psychiatr Res; 2018 Jan; 96():209-217. PubMed ID: 29102815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism.
    Cavallini MC; Di Bella D; Siliprandi F; Malchiodi F; Bellodi L
    Am J Med Genet; 2002 Apr; 114(3):347-53. PubMed ID: 11920862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder.
    Cavallini MC; Di Bella D; Pasquale L; Henin M; Bellodi L
    Psychiatry Res; 1998 Feb; 77(2):97-104. PubMed ID: 9541145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.